Clovis Oncology Inc Revenue per Employee (CLVS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Clovis Oncology inc   (NASDAQ: CLVS)
 

Clovis Oncology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Clovis Oncology Inc 's Revenue per employee fell on a trailing twelve month basis to $ 288,549, below the company average number of $289,126.
Within the Healthcare sector Employees of 205 other companies have achieved higher revenue per employee. While Clovis Oncology Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1934. Clovis Oncology Inc has 461 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLVS Revenue per Employee (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Revenue Change -19.13 % -12.7 % -10 % -16.93 % -2.21 %
Sales per Employee (TTM) $ 288,549 304,282 314,427 322,683 338,586
CLVS's Total Ranking # 1934 # 0 # 0 # 0 # 0
Seq. Revenue Change -4.6 % -6.14 % -4.78 % -5.14 % 2.98 %

CLVS Company Profile >> Back to CLVS Efficiency Comparisons >> Compare CLVS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 92
Healthcare Sector # 206
Overall Market # 1934

Revenue per Employee Statistics
High Average Low
$ 356,881 $ 289,126 $ 83,620
(Dec 31 2020)   (Sep 30 2017)



Financial Statements
Clovis Oncology Inc 's Revenue MRQ $ 31 Millions Visit CLVS's Income Statement
Clovis Oncology Inc 's Revenues TTM $ 133 Millions Visit CLVS's aggregate revenue growth
What are CLVS's Sales? Visit CLVS's Sales by Segment




Other Ratios
Clovis Oncology Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CLVS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CLVS's Competitors
Revenue per Employee for CLVS's Suppliers
Revenue per Employee for CLVS's Customers

You may also want to know
CLVS's Sales Growth Rates CLVS's Pe Price to earnings ratio CLVS's Receivables Turnover Ratio CLVS's Stock Quote
CLVS's Net Income Growth Rates CLVS's Ps Price to Sales ratio CLVS's Sales per Employee CLVS's Asset Turnover Ratio
CLVS's Net Margin CLVS's Pb Price to Book ratio CLVS's Financial Strength Ratios CLVS's Dividend Payout Ratio
Date modified: 2026-08-29T17:19:40+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2022Number of Employees Sep 30 2022
Henry Schein Inc   504,260.88 $ 12,606.522  Million 25,000 
Dynatronics Corporation  501,031.76 $ 44.091  Million 88 
Voyager Therapeutics Inc   500,219.86 $ 70.531  Million 141 
Aveanna Healthcare Holdings Inc   500,162.29 $ 1,750.568  Million 3,500 
Syros Pharmaceuticals Inc   498,638.30 $ 23.436  Million 47 
Inogen Inc   485,462.15 $ 365.553  Million 753 
Vanda Pharmaceuticals Inc   483,900.56 $ 257.919  Million 533 
Kiniksa Pharmaceuticals International Plc  483,718.58 $ 177.041  Million 366 
Whitehawk Therapeutics Inc   483,000.00 $ 11.109  Million 23 
Wearable Health Solutions, Inc.  479,750.00 $ 0.960  Million 2 
Elite Pharmaceuticals Inc   476,960.08 $ 31.002  Million 65 
Cardiovascular Systems Inc   475,050.00 $ 237.525  Million 500 
Precigen Inc   474,218.75 $ 75.875  Million 160 
Dyadic International Inc   470,288.00 $ 2.351  Million 5 
Emmaus Life Sciences Inc   469,090.91 $ 15.480  Million 33 
Quidelortho Corp  467,127.08 $ 3,036.326  Million 6,500 
Biofrontera Inc   467,010.87 $ 42.965  Million 92 
Option Care Health Inc   465,124.12 $ 3,844.716  Million 8,266 
C4 Therapeutics Inc   464,615.38 $ 48.320  Million 104 
Arcturus Therapeutics Holdings Inc   463,963.96 $ 51.500  Million 111 
Co diagnostics Inc   462,765.80 $ 53.218  Million 115 
Maxcyte inc   461,427.47 $ 41.990  Million 91 
Poseida Therapeutics Inc   459,633.33 $ 151.679  Million 330 
Elanco Animal Health Incorporated  458,888.89 $ 4,543.000  Million 9,900 
Arvinas Inc   455,818.83 $ 112.131  Million 246 
Blueprint Medicines Corporation  455,690.72 $ 265.212  Million 582 
Teva Pharmaceutical Industries Limited  445,979.38 $ 15,141.000  Million 33,950 
Cumberland Pharmaceuticals Inc   443,087.42 $ 41.207  Million 93 
Agile Therapeutics Inc  442,210.53 $ 8.402  Million 19 
Surgalign Holdings Inc   440,402.12 $ 83.236  Million 189 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.